Rogers (ROG) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
27 Dec, 2025Executive summary
Q1 2025 net sales were $190.5 million, down 0.9% sequentially and 10.7% year-over-year, with gross margin at 29.9% and adjusted EPS of $0.27; cash position increased to $175.6 million, aided by a facility sale.
New design wins in EV/HEV, industrial, and renewable energy markets, with increased opportunities in China and a major European OEM.
Aggressive cost reduction actions, including facility consolidations, workforce reductions, and discretionary spend cuts, are expected to yield $25 million in 2025 savings.
Restructuring charges of $5.9 million were recognized, mainly for winding down AES operations in Belgium and global workforce reduction.
Local-for-local manufacturing and mitigation plans are in place to offset tariff impacts, especially for U.S.-China trade.
Financial highlights
Net sales: $190.5 million, down 1% sequentially and 10.7% year-over-year, impacted by $3 million FX and lower portable electronics.
Gross margin: 29.9%, down from 32.1% in Q4 and 32.0% in Q1 2024.
Adjusted EPS: $0.27, down from $0.46 in Q4; GAAP net loss: $1.4 million.
Adjusted EBITDA: $19.5 million (10.2% margin), down from $23.3 million in Q4 and $28.3 million in Q1 2024.
Cash and cash equivalents: $175.6 million at quarter end, up from $159.8 million at year-end 2024.
Outlook and guidance
Q2 2025 net sales expected between $190 million and $205 million; gross margin guidance 31%-33%.
Adjusted EPS for Q2 projected at $0.30-$0.70; GAAP EPS guidance: $0.00–$0.40.
CapEx for 2025 reduced to $30-$40 million, funded by operations and cash on hand.
Management expects ongoing cost improvements from manufacturing optimization and workforce reductions.
Growth opportunities anticipated in EV/HEV, ADAS, aerospace, defense, and renewable energy markets.
Latest events from Rogers
- Q4 sales and margins rose on cost savings; 2026 outlook projects continued growth.ROG
Q4 202518 Feb 2026 - Q4 results met guidance; cost controls and innovation support H2 2025 recovery plans.ROG
Q4 20243 Feb 2026 - Gross margin and adjusted EPS improved in Q2, with EMS growth offsetting AES softness.ROG
Q2 20242 Feb 2026 - Strong growth in EV and high-tech markets, with margin expansion and global innovation focus.ROG
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Earnings beat guidance, but sales fell on weak EV/HEV demand; Q4 outlook remains cautious.ROG
Q3 202418 Jan 2026 - Operational improvements and innovation in high-growth markets drive optimism for H2 recovery.ROG
Gabelli Funds' 16th Annual Specialty Chemicals Symposium19 Dec 2025 - Annual meeting to elect nine directors, ratify PwC, and approve executive pay, with strong governance focus.ROG
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and say-on-pay up for vote at May 2025 meeting.ROG
Proxy Filing2 Dec 2025 - Q2 2025 saw sequential sales growth, curamikⓇ impairments, and major restructuring.ROG
Q2 202516 Nov 2025